🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and the effectiveness o...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2022-02-15
Trial ID
NCT05236686
Treatments Being Tested
Ovarian cancer (OC) is one of the most lethal cancers in the world due to l...
Status
Recruiting
Location
Catharina Hospital
Start Date
2025-01-01
Trial ID
NCT06611072
Treatments Being Tested
This is a randomized, open, comparative, multi-centre study which will recr...
Status
Completed
Location
Institut Ste Catherine
Start Date
2017-10-18
Trial ID
NCT03249142
Patients with advanced ovarian cancer (FIGO stage III C) and highly dissemi...
Status
Completed
Location
Catholic University of the Sacred Heart
Start Date
2011-10-01
Trial ID
NCT01461850
Cytoreductive surgery is currently the main treatment for advanced epitheli...
Status
Completed
Location
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Start Date
2011-12
Trial ID
NCT04604964
Treatments Being Tested
This is a retrospective observational study to evaluate the integrative pro...
Status
Active Not Recruiting
Location
Sohag university hospital
Start Date
2026-06-01
Trial ID
NCT07678008
This study was designed to assess the safety and efficacy of neoadjuvant th...
Status
Unknown
Location
NMRC of Oncology named after N.N.Petrov of MoH of Russia
Start Date
2020-10-01
Trial ID
NCT04747717
Treatments Being Tested
Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2019-12-01
Trial ID
NCT04261465
Treatments Being Tested
Patients with extensive and bulky disease are often those whose initial sur...
Status
Completed
Location
Centre Paul Papin
Start Date
2012-06
Trial ID
NCT01583322
Chemotherapy resistance is the greatest contributor to mortality in advance...
Status
Recruiting
Location
Turku University Hospital
Start Date
2012-02-01
Trial ID
NCT04846933
Treatments Being Tested